CHEK2 and breast carcinoma: The moderate-risk genes—CHEK2, ATM, and PALB2—had positive yields of 2.0% (n = 66), 1.0% (n = 33), and 0.8% (n = 25), respectively, among the 3,315 women with breast cancer and no previous testing.